A drug-drug interaction study to assess the potential effect of acid-reducing agent, lansoprazole, on quizartinib pharmacokinetics.
Cancer Chemother Pharmacol
; 84(4): 799-807, 2019 10.
Article
in En
| MEDLINE
| ID: mdl-31385001
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phenylurea Compounds
/
Benzothiazoles
/
Lansoprazole
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Chemother Pharmacol
Year:
2019
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Alemania